NYSE · MMSI
Healthcare · Medical - Instruments & Supplies
$86.24
Down-$7.15 (-7.66%)
Updated Oct 31, 2026, 4:08 PM
SID Score
4.8/10
Composite research score
Smart Money
58/100
Neutral
Price performance · MMSI
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
MMSI closed at $86.24 after 21 trading sessions, up 1.02% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $91.00 | $92.445 | $84.00 | $86.24 | 1.8M |
| Oct 29, 2026 | $93.09 | $93.78 | $91.30 | $93.39 | 979.23K |
| Oct 28, 2026 | $92.71 | $94.12 | $92.0103 | $92.21 | 543.39K |
| Oct 27, 2026 | $94.20 | $94.45 | $93.12 | $93.53 | 731.98K |
| Oct 26, 2026 | $93.42 | $94.85 | $93.30 | $94.20 | 1M |
| Oct 23, 2026 | $93.57 | $93.87 | $92.77 | $93.30 | 750.56K |
| Oct 22, 2026 | $91.40 | $94.16 | $89.1286 | $93.94 | 655.04K |
| Oct 21, 2026 | $90.43 | $92.05 | $90.00 | $91.40 | 543.17K |
| Oct 20, 2026 | $90.86 | $91.59 | $90.46 | $91.18 | 688.8K |
| Oct 19, 2026 | $88.85 | $90.74 | $88.85 | $89.96 | 580.99K |
| Oct 16, 2026 | $89.83 | $90.24 | $88.52 | $89.20 | 488.37K |
| Oct 15, 2026 | $88.45 | $90.26 | $88.42 | $89.57 | 707.24K |
| Oct 14, 2026 | $88.14 | $89.06 | $86.55 | $87.16 | 608.01K |
| Oct 13, 2026 | $90.00 | $90.99 | $87.84 | $88.14 | 842.16K |
| Oct 12, 2026 | $87.65 | $89.93 | $87.65 | $89.75 | 859.8K |
| Oct 9, 2026 | $85.41 | $87.62 | $85.41 | $87.21 | 480.79K |
| Oct 8, 2026 | $85.02 | $85.81 | $83.94 | $85.25 | 579.4K |
| Oct 7, 2026 | $84.93 | $86.01 | $84.73 | $85.09 | 468.06K |
| Oct 6, 2026 | $87.45 | $88.90 | $84.22 | $84.96 | 587.66K |
| Oct 5, 2026 | $85.40 | $87.57 | $84.74 | $87.14 | 699.16K |
| Oct 2, 2026 | $86.73 | $86.855 | $85.24 | $85.37 | 492.41K |
The latest Smart Investors Daily articles mentioning MMSI.
Company
Market Activity
Research & News
MMSI research
Company profile and research snapshot.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 30, 2026 | Needham | Buy | — |
| Oct 30, 2026 | BTIG | Buy | — |
| Oct 27, 2026 | Freedom Capital Markets | Hold | — |
| Sep 29, 2026 | Needham | Buy | — |
| Aug 13, 2026 | B of A Securities | Neutral | — |
No generated briefing is available yet.
Yahoo · Oct 15, 2026
BDX's Revello stent shows strong nine-month AGILITY trial results, with high vessel patency and low failure rates, boosting its peripheral vascular prospects.
Yahoo · Oct 15, 2026
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Merit Medical Systems (NASDAQ:MMSI) and its peers.
Yahoo · Oct 15, 2026
DOCS extends its 13-year partnership with U.S. News, strengthening its role in physician searches, appointment booking and hospital rankings.
Yahoo · Oct 15, 2026
West Pharmaceutical shares have surged 36.1% YTD, fueled by strong demand for high-value components, earnings momentum and raised guidance. Can the rally continue?
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MMSI.
